Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Deforolimus in Treatment of Sarcoma - SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				13 and over				Pharmaceutical / Industry				AP23573-07-302 NCT00538239


2.		A Multi-Center Phase I Study of AP23573 in Pediatric Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 17				Other				SUN08-01 NCT00704054


3.		Oral Deforolimus With Trastuzumab for Patients With HER2-Positive Trastuzumab-Refractory Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				AP23573-08-207 NCT00736970


4.		Clinical Trial of Deforolimus Compared to Progestin in Endometrial Carcinoma Following One Line of Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				AP23573-07-205 NCT00739830

First Published: 9/23/2008


5.		Phase II Study of Deforolimus in Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				Over 18				Other, Pharmaceutical / Industry				CAN-NCIC-IND192 IND.192, ARIAD-CAN-NCIC-IND192, NCT00770185, ind192


6.		Bicalutamide and Deforolimus in Men With Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				2008_572 MK8669-002, NCT00777959


7.		Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				AP23573-08-111 NCT00781846

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute